医学
乌斯特基努马
溃疡性结肠炎
维持疗法
诱导疗法
重症监护医学
内科学
疾病
英夫利昔单抗
化疗
作者
Bruce E. Sands,William J. Sandborn,Remo Panaccione,Christopher D. O’Brien,Shouxin Zhang,Jewel Johanns,Omoniyi J. Adedokun,Katherine Li,Laurent Peyrin‐Biroulet,Gert Van Assche,Silvio Danese,Stephan R. Targan,María T. Abreu,Tadakazu Hisamatsu,Philippe Szapary,Colleen Marano
标识
DOI：10.1056/nejmoa1900750
摘要
The efficacy of ustekinumab, an antagonist of the p40 subunit of interleukin-12 and interleukin-23, as induction and maintenance therapy in patients with ulcerative colitis is unknown.
科研通智能强力驱动
Strongly Powered by AbleSci AI
不配.
Henry
个性的紫菜
有人
Leonardi
iNk
Singularity
8R60d8
浅尝离白
肯德鸭
itsserene
寻道图强
yufanhui
竹筏过海
pcr163
LY
乐乐乐乐乐乐
tuanheqi
薰硝壤
HEIKU
皖公网安备34019202002308
